A TRIAL OF SODIUM VALPROATE IN TARDIVE-DYSKINESIA

This study reports the results of an open trial of Sodium Valproate in tardive-dyskinesia. Fifteen patients identified having tardive dyskinesia by two psychiatrists independently were treated with Sodium Valproate in dosage of 1200 mg/day for 4 weeks. Assessments were made on abbreviated Dyskinesia...

Descripción completa

Detalles Bibliográficos
Autores principales: Chadda, R., Kulhara, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 1986
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172504/
https://www.ncbi.nlm.nih.gov/pubmed/21927146
Descripción
Sumario:This study reports the results of an open trial of Sodium Valproate in tardive-dyskinesia. Fifteen patients identified having tardive dyskinesia by two psychiatrists independently were treated with Sodium Valproate in dosage of 1200 mg/day for 4 weeks. Assessments were made on abbreviated Dyskinesia Scale. There was statistically significant improvement after 2 and 4 weeks of treatment. Authors found Sodium Valproate quite effective in the management of tardive-dyskinesia.

Ejemplares similares